AbstractBackground: bosutinib is in a group of medications named tyrosine kinase inhibitors and is utilized to treat definite type of chronic myeloid leukemia. It might inhibit an abnormal protein that stimulates cancer cells to proliferate. bosutinib administration have some respiratory complications. N- acetylcysteine (NAC) is drug that could be utilized to treat conditions as cystic fibrosis an...